We present the first data on disease severity-associated changes in the serum levels of the growth factor EGF, the inflammatory cytokines MIF and IL-6, and the inhibitory sensory neuropeptide SOM in patients with endometriosis. This evidence concerns the gene GRHL3 and endometriosis.